Europe Pharmaceutical Packaging Market: Size, Share, Growth, Trends and Forecast (2025–2031)

Market Overview

The Europe Pharmaceutical Packaging Market is witnessing steady growth due to increasing pharmaceutical production, rising demand for biologics, and stringent regulatory requirements for drug safety and traceability. Pharmaceutical packaging plays a critical role in ensuring product integrity, maintaining patient safety, and complying with evolving industry regulations. The growing adoption of smart packaging technologies, anti-counterfeiting solutions, sustainable materials, and personalized medicine is further transforming the market landscape.

Request Sample Link:
https://packagingmarketinsights.com/report/europe-pharmaceutical-packaging-market/request-sample

Market Size and Forecast

The Europe Pharmaceutical Packaging Market was valued at approximately USD 28.4 billion in 2025 and is projected to reach USD 39.7 billion by 2030, expanding at a CAGR of 6.1% during 2025–2031.

The expansion of pharmaceutical manufacturing, increasing healthcare spending, and the growing aging population continue to support market growth. Rising consumption of prescription drugs, over-the-counter medicines, and specialty biologics is driving the demand for advanced pharmaceutical packaging solutions across Europe.

Key market highlights include:

• Europe accounted for 31.2% of the global market share in 2025.

• Asia Pacific is expected to register the fastest CAGR of 7.4%.

• Primary packaging held a 58.6% market share.

• Flexible packaging is projected to grow at a CAGR of 7.1%.

• Plastics accounted for 49.3% of the material segment.

• Biodegradable materials are expected to grow at a CAGR of 8.2%.

• Germany recorded a market size of USD 6.2 billion in 2025 and is expected to reach USD 6.6 billion in 2026.

Market Drivers

Rising Demand for Biologics and Specialty Drugs

The increasing production and use of biologics and specialty pharmaceuticals are significantly contributing to Europe Pharmaceutical Packaging Market growth. These medicines require specialized packaging formats such as prefilled syringes, vials, and temperature-sensitive containers to maintain stability, efficacy, and product quality. As biologics become increasingly important in chronic disease treatment, demand for advanced pharmaceutical packaging solutions continues to rise.

Stringent Regulatory Framework in Europe

Strict regulations governing drug safety, labeling, serialization, and traceability are encouraging pharmaceutical companies to adopt advanced packaging technologies. Tamper-evident packaging, track-and-trace systems, and child-resistant as well as senior-friendly packaging solutions are becoming essential to comply with regulatory requirements while ensuring patient safety.

Market Challenges

The high cost associated with advanced pharmaceutical packaging technologies remains one of the key challenges for the Europe Pharmaceutical Packaging Market. Smart packaging systems, sustainable materials, and regulatory compliance require considerable investments in research, development, and manufacturing capabilities.

Small and medium-sized pharmaceutical companies may face financial limitations in implementing these advanced solutions. Additionally, fluctuations in raw material prices, particularly for specialized polymers and biodegradable materials, increase production costs and place pressure on profit margins. While automation and material substitution strategies are helping improve cost efficiency, balancing affordability with regulatory compliance remains an ongoing challenge.

Market Opportunities

Growth of Home Healthcare and Self-Administration

The increasing adoption of home healthcare and self-administered medications presents a significant opportunity for the Europe Pharmaceutical Packaging Market. User-friendly packaging formats such as prefilled syringes, autoinjectors, and blister packs are becoming increasingly important as patients seek convenient and safe medication delivery systems.

Expansion of Contract Packaging Services

The growing demand for contract packaging organizations (CPOs) is creating new business opportunities. Pharmaceutical manufacturers are increasingly outsourcing packaging operations to improve efficiency and reduce operational costs. This trend enables packaging providers to strengthen their technological capabilities while expanding their market presence.

Market Segmentation

By Product Type

Primary packaging dominated the market with a 58.6% share, driven by its essential role in protecting pharmaceutical products from contamination while maintaining drug stability. This segment includes bottles, vials, ampoules, and blister packs.

Flexible packaging is projected to witness the fastest growth at a CAGR of 7.1% due to its lightweight design, cost efficiency, and increasing application in unit-dose packaging.

By Material

Plastic materials accounted for the largest market share of 49.3%, supported by their durability, versatility, and cost-effectiveness. Plastic remains widely used in bottles, blister packs, and closures.

Biodegradable materials are expected to register the highest growth rate of 8.2% CAGR as sustainability initiatives and environmental regulations encourage the adoption of eco-friendly alternatives.

By Packaging Type

Primary packaging maintained the dominant position due to its critical function in protecting pharmaceutical products. Secondary packaging, including cartons and labels, also contributes significantly to the market, while tertiary packaging is expected to grow steadily due to increasing logistics requirements and pharmaceutical distribution activities.

By Drug Delivery Mode

Oral drug delivery packaging held the largest share of 45.7%, supported by the widespread use of tablets and capsules packaged in bottles and blister packs.

Injectable packaging is projected to grow at a CAGR of 7.6%, driven by increasing biologics and vaccine usage along with rising demand for prefilled syringes and advanced injectable packaging formats.

By End User

Pharmaceutical manufacturing companies accounted for the largest market share of 62.4% as they require large-scale packaging solutions for drug production.

Contract packaging organizations are expected to grow at a CAGR of 7.3%, reflecting increasing outsourcing activities across the pharmaceutical industry.

Regional Analysis

Europe remained the leading regional market with a 31.2% market share in 2025 and is projected to grow at a CAGR of 6.1%. Germany led the region due to its strong pharmaceutical manufacturing capabilities, high-quality packaging standards, and focus on innovation.

North America accounted for 27.8% of the market and is expected to grow at a CAGR of 5.8%, supported by advanced pharmaceutical infrastructure and high healthcare expenditure. The United States remained the dominant country within the region.

Asia Pacific captured 24.5% of the market and is projected to record the fastest CAGR of 7.4%. China continues to lead regional growth through large-scale pharmaceutical manufacturing, increasing healthcare investments, and rising demand for generic medicines.

The Middle East & Africa represented 8.6% of the market and is expected to grow at a CAGR of 5.2%, with Saudi Arabia leading regional development through healthcare investments and local pharmaceutical manufacturing initiatives.

Latin America accounted for 7.9% of the market and is forecast to grow at a CAGR of 5.5%. Brazil remains the dominant market owing to its expanding pharmaceutical industry and increasing demand for affordable medicines.

Key Players

The Europe Pharmaceutical Packaging Market is moderately fragmented, with companies focusing on innovation, sustainability, advanced materials, and smart packaging technologies.

Leading market participants include:

1. Amcor Plc

2. Gerresheimer AG

3. Schott AG

4. West Pharmaceutical Services Inc.

5. Berry Global Inc.

6. AptarGroup Inc.

7. Bormioli Pharma

8. SGD Pharma

Conclusion

The Europe Pharmaceutical Packaging Market is positioned for steady growth, supported by expanding pharmaceutical manufacturing, increasing biologics production, regulatory compliance requirements, and continued innovation in sustainable and smart packaging solutions. Growth opportunities are expected to emerge from home healthcare, self-administration, and the expansion of contract packaging services, while manufacturers continue addressing cost-related challenges through operational improvements and technological advancements.

As pharmaceutical companies continue investing in advanced, compliant, and patient-friendly packaging solutions, the Europe Pharmaceutical Packaging Market is expected to maintain its positive growth trajectory throughout the forecast period, driven by evolving healthcare needs and continuous innovation across the packaging industry.

Report Link:
https://packagingmarketinsights.com/report/europe-pharmaceutical-packaging-market